International Journal of Neurorehabilitation

Banaki T

Publications

• Review Article
  High Levels of Anti-Ganglioside Antibodies in Patients with Parkinson's Disease Associated with Cognitive Decline
  Author(s): Hatzifilippou E, Arnaoutoglou M, Koutsouraki E, Banaki T, Costa VG and Baloyannis SJHatzifilippou E, Arnaoutoglou M, Koutsouraki E, Banaki T, Costa VG and Baloyannis SJ
  
  Background: Increasing evidence suggests that gangliosides act as important mediators in both demyelination and remyelination. Objective: The purpose of the present study was to investigate the presence of IgM antibodies against GM1, GD1b and GQ1b gangliosides in the sera of in patients who suffered from Parkinson’s disease in correlation with the clinical parameters. Method: The present research is based on the investigation of 44 patients (63.7-73.3 years) for anti-ganglioside antibodies and 44 healthy age- matched individuals, as normal controls, using Enzyme-Linked Immuno-Sorbent Assays. Results: The patients revealed increased levels of the tested antibodies, compared to normal controls (p=0.0005). A correlation between IgM anti-GM1 and the level of cognitive impairment (Minimental State Examination, p=0.003; Unified Parkinson’s Disease Rating Scale I, p=0.013) was al.. Read More»
  DOI: 10.4172/2376-0281.1000159

  Abstract PDF